Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested Capital

AIM ImmunoTech (AIM) Gross Margin (2018 - 2023)

Historic Gross Margin for ImmunoTech (AIM) over the last 6 years, with Q4 2023 value amounting to 81.54%.

  • ImmunoTech's Gross Margin changed N/A to 81.54% in Q4 2023 from the same period last year, while for Dec 2023 it was 233.33%, marking a year-over-year change of. This contributed to the annual value of 81.76% for FY2024, which is 25600.0% up from last year.
  • Latest data reveals that ImmunoTech reported Gross Margin of 81.54% as of Q4 2023.
  • In the past 5 years, ImmunoTech's Gross Margin registered a high of 81.54% during Q4 2023, and its lowest value of 466.67% during Q3 2020.